Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
308.8 SAR | +0.26% | +8.20% | +8.73% |
Jun. 03 | Dr. Sulaiman Al Habib Medical Services Secures Final License for Hospital Operations in Saudi Arabia | MT |
May. 19 | Dr. Sulaiman Al Habib Medical Services Declares Q1 Dividend | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
Weaknesses
- With an expected P/E ratio at 49.08 and 40.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.73% | 28.74B | C+ | ||
+26.08% | 88.38B | C+ | ||
-23.66% | 77.56B | B- | ||
+7.45% | 18.45B | A- | ||
-13.80% | 16.57B | B | ||
+2.60% | 15.81B | A- | ||
+78.26% | 13.65B | C- | ||
+82.29% | 13.06B | C+ | ||
+3.66% | 12.61B | A- | ||
+35.15% | 12.56B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4013 Stock
- Ratings Dr. Sulaiman Al Habib Medical Services Group Company